The accumulation of protein aggregates is toxic and linked to different diseases such as neurodegenerative disorders, but the role of the immune system to target and destroy aggregate-carrying cells is still relatively unknown. Here we show a substrate-specific presentation of antigenic peptides to the direct MHC class I pathway via autophagy. We observed no difference in presentation of peptides derived from the viral EBNA1 protein following suppression of autophagy by knocking down Atg5 and Atg12. However, the same knock down treatment suppressed the presentation from ovalbumin. Fusing the aggregate-prone poly-glutamine (PolyQ) to the ovalbumin had no effect on antigen presentation via autophagy. Interestingly, fusing the EBNA1-derived gly-ala repeat (GAr) sequence to ovalbumin rendered the presentation Atg5/12 independent. We also demonstrate that the relative levels of protein expression did not affect autophagy-mediated antigen presentation. These data suggest a substrate-dependent presentation of antigenic peptides for the MHC class I pathway via autophagy and indicate that the GAr of the EBNA1 illustrates a novel virus-mediated mechanism for immune evasion of autophagy-dependent antigen presentation.

Department of Medical Biosciences Building 6M Umeå University 901 85 Umeå Sweden

ICCVS University of Gdańsk Science ul Wita Stwosza 63 80 308 Gdańsk Poland

Inserm UMRS1131 Institut de Génétique Moléculaire Université Paris 7 Hôpital St Louis F 75010 Paris France

Institut Necker Enfants Malades INSERM U1151 CNRS UMR 8253 Université de Paris Faculté de Médecine Necker France

ISP INRAE Université de Tours UMR1282 Tours Nouzilly France

RECAMO Masaryk Memorial Cancer Institute Zluty kopec 7 65653 Brno Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc22018918

003      

CZ-PrNML

005      

20220804135203.0

007      

ta

008      

220720s2022 ne f 000 0|eng||

009      

AR

024    7_

$a 10.1016/j.cellimm.2022.104484 $2 doi

035    __

$a (PubMed)35247713

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a ne

100    1_

$a Tovar Fernandez, Maria C $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, F-75010 Paris, France; ICCVS, University of Gdańsk, Science, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland

245    10

$a Substrate-specific presentation of MHC class I-restricted antigens via autophagy pathway / $c MC. Tovar Fernandez, EM. Sroka, M. Lavigne, A. Thermou, C. Daskalogianni, B. Manoury, R. Prado Martins, R. Fahraeus

520    9_

$a The accumulation of protein aggregates is toxic and linked to different diseases such as neurodegenerative disorders, but the role of the immune system to target and destroy aggregate-carrying cells is still relatively unknown. Here we show a substrate-specific presentation of antigenic peptides to the direct MHC class I pathway via autophagy. We observed no difference in presentation of peptides derived from the viral EBNA1 protein following suppression of autophagy by knocking down Atg5 and Atg12. However, the same knock down treatment suppressed the presentation from ovalbumin. Fusing the aggregate-prone poly-glutamine (PolyQ) to the ovalbumin had no effect on antigen presentation via autophagy. Interestingly, fusing the EBNA1-derived gly-ala repeat (GAr) sequence to ovalbumin rendered the presentation Atg5/12 independent. We also demonstrate that the relative levels of protein expression did not affect autophagy-mediated antigen presentation. These data suggest a substrate-dependent presentation of antigenic peptides for the MHC class I pathway via autophagy and indicate that the GAr of the EBNA1 illustrates a novel virus-mediated mechanism for immune evasion of autophagy-dependent antigen presentation.

650    12

$a prezentace antigenu $7 D017951

650    _2

$a antigeny $7 D000941

650    _2

$a autofagie $7 D001343

650    12

$a histokompatibilita - antigeny třídy I $7 D015395

650    _2

$a histokompatibilita - antigeny třídy II $x metabolismus $7 D000949

650    _2

$a imunitní únik $7 D057131

650    _2

$a ovalbumin $7 D010047

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Sroka, Ewa M $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, F-75010 Paris, France; ICCVS, University of Gdańsk, Science, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland

700    1_

$a Lavigne, Mathilde $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, F-75010 Paris, France

700    1_

$a Thermou, Aikaterini $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, F-75010 Paris, France; ICCVS, University of Gdańsk, Science, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland

700    1_

$a Daskalogianni, Chrysoula $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, F-75010 Paris, France; ICCVS, University of Gdańsk, Science, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland

700    1_

$a Manoury, Bénédicte $u Institut Necker Enfants Malades, INSERM U1151-CNRS UMR 8253, Université de Paris, Faculté de Médecine Necker, France

700    1_

$a Prado Martins, Rodrigo $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, F-75010 Paris, France; ISP, INRAE, Université de Tours, UMR1282, Tours, Nouzilly, France

700    1_

$a Fahraeus, Robin $u Inserm UMRS1131, Institut de Génétique Moléculaire, Université Paris 7, Hôpital St. Louis, F-75010 Paris, France; ICCVS, University of Gdańsk, Science, ul. Wita Stwosza 63, 80-308 Gdańsk, Poland; Department of Medical Biosciences, Building 6M, Umeå University, 901 85 Umeå, Sweden; RECAMO, Masaryk Memorial Cancer Institute, Zluty kopec 7, 65653 Brno, Czech Republic. Electronic address: robin.fahraeus@inserm.fr

773    0_

$w MED00001079 $t Cellular immunology $x 1090-2163 $g Roč. 374, č. - (2022), s. 104484

856    41

$u https://pubmed.ncbi.nlm.nih.gov/35247713 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y p $z 0

990    __

$a 20220720 $b ABA008

991    __

$a 20220804135156 $b ABA008

999    __

$a ok $b bmc $g 1822489 $s 1170161

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2022 $b 374 $c - $d 104484 $e 20220217 $i 1090-2163 $m Cellular immunology $n Cell Immunol $x MED00001079

LZP    __

$a Pubmed-20220720